OpGen is a precision medicine company engaged in molecular diagnostics and informatics. Along with its subsidiaries, Curetis GmbH and Ares Genetics GmbH, Co. is developing and commercializing molecular microbiology solutions helping to guide clinicians with actionable information about life threatening infections. Co.'s existing product portfolio includes Unyvero, Acuitas Antimicrobial Resistance (AMR) Gene Panel, and the ARES Technology Platform including ARES reference database on antimicrobial resistance, Next Generation Sequencing technology and Artificial Intelligence-powered bioinformatics solutions for AMR surveillance, outbreak analysis, and antibiotic response prediction.